TYR and melanoma: C3G, EC, and CH, exhibit no substantial cytotoxicity (100 μg/mL) on murine melanoma cells marking them as ideal candidates for the assessment of mammalian tyrosinase inhibition by comparison to ARB inhibitor (Fig. 11).